Skip to content
10-Q

Quarterly Report

CALYPTE BIOMEDICAL CORP

0001437749-12-005105

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 15, 2012 700.17M sh
Shares Diluted Q1 2012 · Mar 31, 2012 566.24M sh
Shares Diluted Q1 2012 · Mar 31, 2011 539.83M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$267K
Operating Cash Flow Q1 2012 · Mar 31, 2011 $81K
Cash And Equivalents Q1 2012 · Mar 31, 2012 $63K
Cash And Equivalents Q1 2012 · Dec 31, 2011 $10K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $252K
Cash And Equivalents Q1 2012 · Dec 31, 2010 $79K
Stockholders Equity Q1 2012 · Mar 31, 2012 −$4.48M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$5.11M
Current Liabilities Q1 2012 · Mar 31, 2012 $2.75M
Current Liabilities Q1 2012 · Dec 31, 2011 $3.41M
Total Liabilities Q1 2012 · Mar 31, 2012 $6.44M
Total Liabilities Q1 2012 · Dec 31, 2011 $7.07M
Current Assets Q1 2012 · Mar 31, 2012 $261K
Current Assets Q1 2012 · Dec 31, 2011 $227K
Total Assets Q1 2012 · Mar 31, 2012 $1.95M
Total Assets Q1 2012 · Dec 31, 2011 $1.96M
Sga Expense Q1 2012 · Mar 31, 2012 $202K
Sga Expense Q1 2012 · Mar 31, 2011 $249K
Rd Expense Q1 2012 · Mar 31, 2012 $74K
Rd Expense Q1 2012 · Mar 31, 2011 $74K
Net Income Q1 2012 · Mar 31, 2012 −$290K
Net Income Q1 2012 · Mar 31, 2011 $101K
Operating Income Q1 2012 · Mar 31, 2012 −$258K
Operating Income Q1 2012 · Mar 31, 2011 −$240K
Cost Of Revenue Q1 2012 · Mar 31, 2012 $53K
Cost Of Revenue Q1 2012 · Mar 31, 2011 $180K